Pentamethonium (bromide)

• Description :

  Pentamethonium bromide is a ganglion blocker that exhibits antihypertensive and vasodilatory activities[1].

• UNSPSC :

  12352211

• Hazard Statement :

  H315-H319-H335

• Target :

  Endogenous Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/pentamethonium-bromide.html

• Smiles :

  C[N+](C)(C)CCCCC[N+](C)(C)C.[Br-].[Br-]

• Molecular Formula :

  C11H28Br2N2

• Molecular Weight :

  348.16

• Precautions :

  P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]BURT CC, et, al. Pentamethonium and hexamethonium iodide in investigation of peripheral vascular disease and hypertension. Br Med J. 1950 Feb 25;1 (4651) :455-60. |[2]DAVISON MHA, et, al. Pentamethonium iodide in anaesthesia. Lancet. 1950 Feb 11;1 (6598) :252.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [541-20-8]